Found: 18
Select item for more details and to access through your institution.
Brief research report: impact of vaccination on antibody responses and mortality from severe COVID-19.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1325243
- By:
- Publication type:
- Article
Brief research report: impact of vaccination on antibody responses and mortality from severe COVID-19.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1325243
- By:
- Publication type:
- Article
Translational and oncologic significance of tertiary lymphoid structures in pancreatic adenocarcinoma.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1324093
- By:
- Publication type:
- Article
Pre-treatment inflamed tumor immune microenvironment is associated with FOLFIRINOX response in pancreatic cancer.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1274783
- By:
- Publication type:
- Article
Increased COVID-19 Mortality and Deficient SARS-CoV-2 Immune Response Are Not Associated with Higher Levels of Endemic Coronavirus Antibodies.
- Published in:
- Immuno, 2023, v. 3, n. 3, p. 330, doi. 10.3390/immuno3030020
- By:
- Publication type:
- Article
Critical evaluation of an autologous peripheral blood mononuclear cell-based humanized cancer model.
- Published in:
- PLoS ONE, 2022, v. 17, n. 9, p. 1, doi. 10.1371/journal.pone.0273076
- By:
- Publication type:
- Article
Impaired neutralizing antibody response to COVID-19 mRNA vaccines in cancer patients.
- Published in:
- Cell & Bioscience, 2021, v. 11, n. 1, p. 1, doi. 10.1186/s13578-021-00713-2
- By:
- Publication type:
- Article
Differential immune signatures in the tumor microenvironment are associated with colon cancer racial disparities.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 5, p. 1805, doi. 10.1002/cam4.3753
- By:
- Publication type:
- Article
Ex vivo blockade of PI3K gamma or delta signaling enhances the antitumor potency of adoptively transferred CD8<sup>+</sup> T cells.
- Published in:
- European Journal of Immunology, 2020, v. 50, n. 9, p. 1386, doi. 10.1002/eji.201948455
- By:
- Publication type:
- Article
Thrombin contributes to cancer immune evasion via proteolysis of platelet-bound GARP to activate LTGF-β.
- Published in:
- Science Translational Medicine, 2020, v. 12, n. 525, p. 1, doi. 10.1126/scitranslmed.aay4860
- By:
- Publication type:
- Article
Genomics meets immunity in pancreatic cancer: Current research and future directions for pancreatic adenocarcinoma immunotherapy.
- Published in:
- Oncology Reviews, 2019, v. 13, n. 2, p. 102, doi. 10.4081/oncol.2019.430
- By:
- Publication type:
- Article
Fueling Cancer Immunotherapy With Common Gamma Chain Cytokines.
- Published in:
- Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.00263
- By:
- Publication type:
- Article
Investigation of Zebrafish Larvae Behavior as Precursor for Suborbital Flights: Feasibility Study.
- Published in:
- Gravitational & Space Research, 2018, v. 6, n. 1, p. 37, doi. 10.2478/gsr-2018-0004
- By:
- Publication type:
- Article
The clinical implications of immunogenomics in colorectal cancer: A path for precision medicine.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Platelets subvert T cell immunity against cancer via GARP-TGFβ axis.
- Published in:
- Science Immunology, 2017, v. 2, n. 11, p. 1, doi. 10.1126/sciimmunol.aai7911
- By:
- Publication type:
- Article
Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer.
- Published in:
- Journal of Hematology & Oncology, 2017, v. 10, p. 1, doi. 10.1186/s13045-017-0459-2
- By:
- Publication type:
- Article
IL-2Rα mediates temporal regulation of IL-2 signaling and enhances immunotherapy.
- Published in:
- Science Translational Medicine, 2015, v. 7, n. 311, p. 1, doi. 10.1126/scitranslmed.aac8155
- By:
- Publication type:
- Article
G-CSF/anti-G-CSF antibody complexes drive the potent recovery and expansion of CD11b<sup>+</sup>Gr-1<sup>+</sup> myeloid cells without ompromising CD8<sup>+</sup> T cell immune responses.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-75
- By:
- Publication type:
- Article